[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2061394B1 - MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. - Google Patents

MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT.

Info

Publication number
ES2061394B1
ES2061394B1 ES9300218A ES9300218A ES2061394B1 ES 2061394 B1 ES2061394 B1 ES 2061394B1 ES 9300218 A ES9300218 A ES 9300218A ES 9300218 A ES9300218 A ES 9300218A ES 2061394 B1 ES2061394 B1 ES 2061394B1
Authority
ES
Spain
Prior art keywords
potassic
granulate
citrate
manufacturing procedure
delayed assignment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9300218A
Other languages
Spanish (es)
Other versions
ES2061394A1 (en
Inventor
Ambros Rafael Foguet
Navarro Carlos Fernandez
Mu Oz Aurelio Sacristan
Hernandez Jose A Ortiz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robert S A Lab
Original Assignee
Robert S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robert S A Lab filed Critical Robert S A Lab
Priority to ES9300218A priority Critical patent/ES2061394B1/en
Publication of ES2061394A1 publication Critical patent/ES2061394A1/en
Application granted granted Critical
Publication of ES2061394B1 publication Critical patent/ES2061394B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO DE FABRICACION DE UN GRANULADO DE CITRATO POTASICO CON CESION RETARDADA. CONSISTE EN LA PREPARACION DE UN GRANULADO DE CITRATO POTASICO, EL CUAL ES UTIL PARA LA POSTERIOR PREPARACION DE DIVERSAS FORMAS FARMACEUTICAS, PREFERENTEMENTE COMPRIMIDOS, QUE SE EMPLEAN PARA EVITAR LA FORMACION DE CALCULOS RENALES DE OXALATO CALCICO, FOSFATO CALCICO O ACIDO URICO. ASIMISMO, FAVORECE LA CESION RETARDADA DEL PRINCIPIO ACTIVO, CON EL FIN DE QUE EL EFECTO TERAPEUTICO SE MANTENGA ESTABLE A LO LARGO DEL TIEMPO Y PUEDA DISMINUIRSE EL NUMERO DE ADMINISTRACIONES.MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. IT CONSISTS IN THE PREPARATION OF A POTASSIC CITRATE GRANULATE, WHICH IS USEFUL FOR THE SUBSEQUENT PREPARATION OF DIFFERENT PHARMACEUTICAL FORMS, PREFERABLY COMPRESSED, THAT ARE USED TO AVOID THE FORMATION OF KIDNEY CALCIUM OXALATE CALCIUM, PHOSPHATE ACID FURTHER, IT DELIVERS THE DELAYED ASSIGNMENT OF THE ACTIVE SUBSTANCE, IN ORDER THAT THE THERAPEUTIC EFFECT REMAINS STABLE OVER TIME AND THE NUMBER OF ADMINISTRATIONS MAY BE DECREASED.

ES9300218A 1993-02-05 1993-02-05 MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT. Expired - Fee Related ES2061394B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9300218A ES2061394B1 (en) 1993-02-05 1993-02-05 MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9300218A ES2061394B1 (en) 1993-02-05 1993-02-05 MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT.

Publications (2)

Publication Number Publication Date
ES2061394A1 ES2061394A1 (en) 1994-12-01
ES2061394B1 true ES2061394B1 (en) 1995-06-16

Family

ID=8280688

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9300218A Expired - Fee Related ES2061394B1 (en) 1993-02-05 1993-02-05 MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT.

Country Status (1)

Country Link
ES (1) ES2061394B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077314A1 (en) * 2005-07-15 2007-04-05 Pak Charles Y C Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
FR3009496B1 (en) * 2013-08-12 2016-02-05 Mohamed Skiba MULTIPARTICULAR FORMS WITH PROLONGED RELEASE, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SAME FOR THE TREATMENT AND / OR PREVENTION OF CYCTINURIA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1312918A (en) * 1969-07-08 1973-04-11 Beecham Group Ltd Veterinary treatment
DE2426811A1 (en) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab PROCESS FOR THE MANUFACTURING OF RETARD TABLETS
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
FR2581541B1 (en) * 1985-05-09 1988-05-20 Rhone Poulenc Sante NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE EXTENDED RELEASE OF AN ACTIVE INGREDIENT AND THEIR PREPARATION METHOD

Also Published As

Publication number Publication date
ES2061394A1 (en) 1994-12-01

Similar Documents

Publication Publication Date Title
ES2194013T3 (en) PHARMACEUTICALLY FIXED HUMAN DRYING BLOOD PLATES
BR0003158A (en) Instant melting oral dosage formulation
PA8438801A1 (en) SUBSTITUTE FOR MILK AND PROCESS FOR ITS MANUFACTURE
AR018829A1 (en) SOLID PHARMACEUTICAL FORMULATIONS OF FAST DISINTEGRATION, ADMINISTRABLE VIA ORAL AND PROCEDURE TO PREPARE THEM
DK0730465T3 (en) Use of angiotensin III and analogues thereof for tissue repair
ES487151A1 (en) New pharmaceutical forms for administration of medicaments by oral route, with programmed release
BR9714509A (en) Solid formulations containing trehalose
IT8123602A0 (en) STABLE SALTS OF S-ADENOSYLMETHIONINE, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH INCLUDE THEM AS THE ACTIVE INGREDIENT.
ES2061394B1 (en) MANUFACTURING PROCEDURE OF A POTASSIC CITRATE GRANULATE WITH DELAYED ASSIGNMENT.
IT8123603A0 (en) STABLE SALTS OF S-ADENOSYLMETHIONINE, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH INCLUDE THEM AS THE ACTIVE INGREDIENT.
ES2160688T3 (en) PROCEDURE TO OBTAIN A PREPARATION OF CLODRONATE.
FR2044216A5 (en) Effervescent tablets prepd by aqueous - granulation
EP0137743A3 (en) Topically administrable pharmaceutical compositions
RU93048332A (en) COMPOSITION BASED ON HEXADECYLPHOSPHOCHOLINE, METHOD OF ITS PRODUCTION, MEDICINAL PRODUCT
FR2338705B1 (en)
SU432098A1 (en)
MY101266A (en) Pharmaceutical formulations
JPS5366422A (en) Mixed insecticide composition
JPS5228751A (en) Chiller unit
BG30916A3 (en) Insecticide means and method for insects fighting
JPS53135930A (en) Preparation of magnesium salt of sulfonic acid ester or sulfuric acid ester
AR025740A1 (en) PROCEDURE FOR THE IDENTIFICATION OF AT LEAST AN ACTIVE CHEMICAL SUBSTANCE IN A MIXTURE OF ACTIVE AND INACTIVE SUBSTANCES WITH RELATIVE MOLAR MASSES OF 150 TO 30,000
JPS5285061A (en) Removal of fluorine ions in solution containing conc. silicic acid
BR8406512A (en) PHOSPHORIC ACID ESTER, PROCESS FOR ITS PRODUCTION AND PESTICIDE COMPOSITION CONTAINING IT AS AN ACTIVE INGREDIENT
MX9205808A (en) AN INJECTABLE VETERINARY COMPOSITION FREE OF HARMFUL SIDE EFFECTS AND A PROCESS FOR ITS PREPARATION.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20180806